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the manubrio-sternal and sternoclavicular joints possess synovium,3'4 extension of synovial disease from adjacent costochondral joints, degenerative processes or trauma. Histological and microradiographic analysis has indicated active inflammation of the articulation in some patients and the absence of inflammation and presence offibrous replacement in others.5 Pathological problems with clinical manifestation in the manubriosternal joint of patients with rheumatoid arthritis are shown in the box. In the former case, bacteraemia and joint sepsis probably occurred secondary to a urinary tract infection in a joint previously compromised by rheumatoid arthritis. This case also illustrates the difficulty in eradication of joint sepsis despite adequate and prolonged administration of appropriate antibiotics. Both cases demonstrate the importance of excluding sepsis in any disproportionally warm and painful joint in a rheumatoid patient. In both patients, fever and peripheral blood leucocytosis were present, characteristic of infection. These responses may be reduced or abolished in rheumatoid patients especially in those debilitated or immunocomprised. Elimination of infection from a joint requires prolonged high-dose antibiotic administration, repeated arthocentesis and sometimes arthrotomy and surgical drainage. Infection is rapidly destructive of intra-articular structures, congruity and stability.
We suggest that clinically obvious manubrio-stemal joint arthritis in a patient with rheumatoid arthritis should be regarded as septic until proved otherwise. Chronic myeloid leukaemia and allogenic bone marrow transplantation in a patient with toxic oil syndrome Sir, We have observed the development of chronic myeloid leukaemia in a woman who had been affected 10 years earlier by the toxic oil syndrome, produced by the ingestion of adulterated rapeseed oil, and in whom an allogenic bone marrow transplant had been accompanied by severe toxic manifestations. The toxic oil syndrome'2 is a multisystemic disease in which the basic lesion is endovasculitis involving vessels of all sizes and located anywhere in the organism. The vascular lesion first affects the intima, followed by inflammatory infiltration and cell proliferation producing, in advanced stages, narrowing and occlusion of the vascular lumen, leading to ischaemia and parenchymal atrophy in some organs (box).3 4 No cases of development of leukaemia in patients affected by the toxic oil syndrome had been previously reported.4
The 35-year-old woman whose case we present here, was diagnosed as having toxic oil syndrome 10 years earlier. The only sequel at the time that the leukaemia was detected, was a mild, predominantly sensory, neuromuscular involvement in the upper limbs. After the diagnosis of Ph-positive chronic myeloid leukaemia, she started treatment with interferon a-2b, but no cytogenetic remission was observed in subsequent haematologic studies.
She was conditioned for an allogenic HLA identical bone marrow transplant from a sister, with fractionated total body irradiation (12 Gy) and cyclophosphamide (60 mg/kg body weight x 2); as prophylaxis for graftversus-host disease, she received cyclosporin A (1.5 mg/kg body weight every 12 h, starting on day -1) and a short course of methotrexate, according to the Seattle protocol.
On the day of the bone marrow infusion, she developed fever and was put on broadspectrum antibiotics and a regimen with amphotericin B, was added later. Her microbiological study and chest X-ray were normal. She had, meanwhile, progressive weight gain, abnormal liver function test (increased of bilirubin and y glutamyl transaminase) and deterioration of renal function. By day +10 she had ascites, tender hepatomegaly and oedemas of her lower limbs, all suggestive of hepatic veno-occlusive disease. A thoracoabdominal computed tomography (CT) scan was carried out which showed hepatosplenomegaly, ascites and retroperitoneal lymphadenopathy. Soon after the transplant she developed severe mucositis.
On day + 13 she was dyspnoeic and a chest X-ray showed consolidation in the lower left lobe, left pleural effusion and a poorly defined nodule in the upper right lobe. Two days later, the nodule enlarged and consolidation at the base of both lungs with bilateral pleural effusion were observed. Because of the suspicion of pulmonary aspergillosis, the dose of amphotericin B was increased.
On day + 20, neutrophil engraftment was detected (neutrophil count> 0.5 x 109/l). figure) . CT scan of the brain showed an epidural haematoma. A bone scan using 740 Mbq of 99 mTc MDP (methylene diphosphonate), showed abnormal uptake in the skull bones and bone marrow imaging using 370 Mbq of 99 mTc colloidal sulphur, done two days after the bone scan showed multiple cold areas in the skull. These radiological findings are suggestive of periorbital and skull bone infarction and adjacent haematoma and swelling secondary to it. The patient received hydroxyurea, blood transfusion and analgesics. After 14 days he regained full movements of the eye and proptosis disappeared.
Sickle cell disease is rarely associated with periorbital and skull bone infarctions. Figure CT scan 
